US Supplement Firm Touts COVID-19 Study, Kicks Off Promotional Campaign With Tae Bo Creator
Executive Summary
Todos Medical, warned in 2021 about COVID-19 claims, could prompt a second warning about linking Tollovid to the coronavirus with recent announcement of test results. Firm also has appointed VPs of marketing and of government affairs since FTC in April 2021 warned about claims on its website, its social media pages and in a store.
You may also be interested in...
US FTC Diagnoses Omicron Symptom: More Fraudulent COVID-19 Treatment Claims
Agency says emergence of Omicron variant spurred marketers of products and services from peptide therapy to herbal remedies, and from nasal irrigation to intravenous drips to make false COVID-19 claims.
It’s Been Over 1100 Days Since MCIT, Still No TCET In Sight
AdvaMed’s new online clock documents the time since CMS promised to replace MCIT, a program guaranteeing coverage for FDA-cleared breakthrough devices.
NAM’S Health Care AI Development Code Of Conduct Addresses Gaps In Current Principles
The National Academy of Medicine developed a code of conduct for health care AI development, as well as commitments for code implementation.